PT1165081E - Processo para a preparacao de preparacoes farmaceuticas cintendo tolperisona, para administracao oral - Google Patents

Processo para a preparacao de preparacoes farmaceuticas cintendo tolperisona, para administracao oral

Info

Publication number
PT1165081E
PT1165081E PT99973809T PT99973809T PT1165081E PT 1165081 E PT1165081 E PT 1165081E PT 99973809 T PT99973809 T PT 99973809T PT 99973809 T PT99973809 T PT 99973809T PT 1165081 E PT1165081 E PT 1165081E
Authority
PT
Portugal
Prior art keywords
tolperisona
cintendo
preparation
oral administration
pharmaceutical preparations
Prior art date
Application number
PT99973809T
Other languages
English (en)
Portuguese (pt)
Inventor
Rudolf Knauthe
Erben Reinhold
Behrens-Stevens Marie-Luise
Original Assignee
Sanochemia Pharmazeutika Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanochemia Pharmazeutika Ag filed Critical Sanochemia Pharmazeutika Ag
Publication of PT1165081E publication Critical patent/PT1165081E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT99973809T 1999-04-01 1999-11-16 Processo para a preparacao de preparacoes farmaceuticas cintendo tolperisona, para administracao oral PT1165081E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0059499A AT409083B (de) 1999-04-01 1999-04-01 Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung

Publications (1)

Publication Number Publication Date
PT1165081E true PT1165081E (pt) 2005-08-31

Family

ID=3494723

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99973809T PT1165081E (pt) 1999-04-01 1999-11-16 Processo para a preparacao de preparacoes farmaceuticas cintendo tolperisona, para administracao oral

Country Status (23)

Country Link
US (1) US6500455B1 (https=)
EP (1) EP1165081B1 (https=)
JP (1) JP2002541107A (https=)
AT (1) AT409083B (https=)
AU (1) AU1136400A (https=)
CA (1) CA2366841C (https=)
CZ (1) CZ20013404A3 (https=)
DE (1) DE59912101D1 (https=)
EE (1) EE04833B1 (https=)
ES (1) ES2168241T3 (https=)
HR (1) HRPK20010706B1 (https=)
HU (1) HUP0200669A3 (https=)
IL (2) IL145559A0 (https=)
NO (1) NO20014738L (https=)
NZ (1) NZ514129A (https=)
PL (1) PL197545B1 (https=)
PT (1) PT1165081E (https=)
RU (1) RU2223098C2 (https=)
SK (1) SK13642001A3 (https=)
TR (1) TR200102811T2 (https=)
UA (1) UA71613C2 (https=)
WO (1) WO2000059508A1 (https=)
YU (1) YU67501A (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0300929A3 (en) * 2003-04-09 2005-06-28 Richter Gedeon Vegyeszet Analgetic and/or muscle relaxant pharmaceutical composition
DE10341923A1 (de) * 2003-09-11 2005-04-07 Heinl, Alexander, Dr.med. Verwendung von Tolperison
US20050089559A1 (en) * 2003-10-23 2005-04-28 Istvan Szelenyi Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
DE10359335A1 (de) * 2003-10-23 2005-05-25 Viatris Gmbh & Co. Kg Kombinationen aus Kaliumkanalöffnern und Natriumkanalinhibitoren oder Natriumkanal beeinflussenden Wirkstoffen zur Behandlung von Schmerzzuständen
AT500144A1 (de) * 2004-03-05 2005-11-15 Sanochemia Pharmazeutika Ag Tolperison enthaltende, pharmazeutische zubereitung mit steuerbarer wirkstofffreisetzung zur oralen verabreichung
MX2008013437A (es) * 2006-04-20 2009-03-06 Sanochemia Pharmazeutika Ag Metodo para administrar tolperisona.
US7960436B2 (en) 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
US8993593B2 (en) * 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
BRPI0716715B1 (pt) 2006-08-23 2021-07-06 Xenon Pharmaceuticals, Inc Derivados de 4-(n-azacicloalquil) anilidas como moduladores de canal de potássio, seus usos, produto, composição, comprimido e cápsula
US8722929B2 (en) 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
CA2670966A1 (en) * 2006-11-28 2008-06-05 Valeant Pharmaceuticals International 1,4 diamino bicyclic retigabine analogues as potassium channel modulators
AT505225A1 (de) 2007-04-26 2008-11-15 Sanochemia Pharmazeutika Ag 0erfahren zur herstellung von hoch reinem 2,4'-dimethyl-3-piperidino-propiophenon (tolperison), dieses enthaltende pharmazeutische zusammensetzungen, sowie tolperison enthaltende wirkstoffformulierungen
US8367684B2 (en) 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
HUP0700485A3 (en) * 2007-07-23 2010-01-28 Richter Gedeon Nyrt Pharmaceutical composition with controlled release containing tolperisone
US8563566B2 (en) 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
US8865732B2 (en) 2008-03-21 2014-10-21 Novartis Ag Heterocyclic compounds and uses thereof
US20100249423A1 (en) * 2009-03-09 2010-09-30 Sanochemia Pharmazeutika Ag Tolperisone controlled release tablet
EA201171109A1 (ru) 2009-03-09 2012-03-30 Динеш Шантилал Пател Новая композиция замедленного высвобождения соединений, выбранных из класса миорелаксантов центрального действия
TWI886158B (zh) 2019-10-10 2025-06-11 加拿大商再諾製藥公司 選擇性鉀通道調節劑之固態晶型
WO2021092439A1 (en) 2019-11-08 2021-05-14 Xenon Pharmaceuticals Inc. Methods of treating depressive disorders
IL304920A (en) 2021-02-09 2023-10-01 Xenon Pharmaceuticals Inc A voltage-gated potassium channel opener for use in the treatment of anhedonia
USD1109826S1 (en) 2024-02-16 2026-01-20 Coulter Ventures, Llc. Weightlifting assembly
WO2026074301A1 (en) 2024-10-02 2026-04-09 Meditop Gyógyszeripari Kft Sustained release oral medicinal product containing tolperisone hydrochloride, its production and use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5154918A (en) * 1974-10-08 1976-05-14 Nippon Kayaku Kk Jozaino seizoho
JPS5191315A (ja) * 1975-02-06 1976-08-10 Anteinaensantoruperizonshirotsupunoseizoho
JPS5340779A (en) * 1976-09-21 1978-04-13 Nippon Kayaku Co Ltd Optically active tolpertisone, their preparation and pharmaceuticals containting the same
JPS58135806A (ja) * 1982-02-08 1983-08-12 Nippon Kayaku Co Ltd 多層コ−チング製剤
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
JPH0637389B2 (ja) * 1986-12-26 1994-05-18 北陸製薬株式会社 頻尿治療剤
JPH0720866B2 (ja) 1987-05-15 1995-03-08 三生製薬株式会社 エペリゾン又はトルペリゾン或いはそれらの塩類含有経皮適用製剤
IL87710A (en) 1987-09-18 1992-06-21 Ciba Geigy Ag Covered floating retard form for controlled release in gastric juice
MY115126A (en) * 1990-04-27 2003-04-30 Seikisui Chemical Co Ltd Percutaneously absorbable eperisone or tolperisone preparation.
US5128145A (en) * 1990-06-13 1992-07-07 Alza Corporation Dosage form for Parkinson's disease, spasticity and muscle spasms
TW209174B (https=) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
ATE154241T1 (de) * 1991-10-01 1997-06-15 Takeda Chemical Industries Ltd Mikropartikeln-zusammenfassung zur verlängerten freigabe und herstellung derselbe
US5811547A (en) * 1992-10-14 1998-09-22 Nippon Shinyaju Co., Ltd. Method for inducing crystalline state transition in medicinal substance
GB9319606D0 (en) * 1993-09-22 1993-11-10 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
WO2000059508A1 (de) 2000-10-12
CZ20013404A3 (cs) 2002-02-13
AU1136400A (en) 2000-10-23
HUP0200669A3 (en) 2002-11-28
IL145559A0 (en) 2002-06-30
EE200100503A (et) 2003-02-17
ES2168241T1 (es) 2002-06-16
UA71613C2 (uk) 2004-12-15
HRPK20010706B1 (en) 2004-12-31
NO20014738D0 (no) 2001-09-28
RU2223098C2 (ru) 2004-02-10
PL197545B1 (pl) 2008-04-30
CA2366841A1 (en) 2000-10-12
SK13642001A3 (sk) 2002-03-05
EP1165081B1 (de) 2005-05-25
EE04833B1 (et) 2007-06-15
NO20014738L (no) 2001-10-23
JP2002541107A (ja) 2002-12-03
AT409083B (de) 2002-05-27
HRP20010706A2 (en) 2003-02-28
IL145559A (en) 2008-12-29
ATA59499A (de) 2001-10-15
YU67501A (sh) 2004-07-15
TR200102811T2 (tr) 2002-05-21
CA2366841C (en) 2008-10-07
DE59912101D1 (de) 2005-06-30
US6500455B1 (en) 2002-12-31
EP1165081A1 (de) 2002-01-02
HUP0200669A2 (hu) 2002-07-29
PL351377A1 (en) 2003-04-07
ES2168241T3 (es) 2005-11-01
NZ514129A (en) 2003-04-29

Similar Documents

Publication Publication Date Title
PT1165081E (pt) Processo para a preparacao de preparacoes farmaceuticas cintendo tolperisona, para administracao oral
EE200100431A (et) 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
BRPI9915208B8 (pt) preparados farmacêutico e de comprimido para a aplicação oral compreendendo moxifloxacina e seu processo de preparação.
EE04464B1 (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
PT1401445E (pt) Anticolinergico cristalino, processo para a sua preparacao e sua utilizacao para a preparacao de um medicamento
IL156097A0 (en) Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds
AU2002227931A1 (en) Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as medicament, and pharmaceutical preparations containing these compounds
NO20021398D0 (no) 2'-substituerte 1,1'-bifenyl-2-karbonamider, fremgangsmåte for fremstilling, deres anvendelse som medikament såvel somfarmasöytiske preparater inneholdende disse
DK1207867T3 (da) Retarderede, orale farmaceutiske indgivelsesformer med tramadol
NO20014035D0 (no) System for oral administrasjon av medikament
BR9810802B1 (pt) composto, composição farmacêutica, e, processo para a preparação de um composto.
GB0029936D0 (en) A pharmaceutical formulation suitable for the treatment of hepititis B, hepititis C and other viral infections of the liver and a process for its preparation
EE200300371A (et) Peroraalselt ja paikselt manustatavad farmatseutilised kopmositsioonid
EE200100706A (et) A-grupi streptogramiinide derivaadid, nende valmistamismeetod ja farmatseutiline kompositsioon
EE200100615A (et) Mikrograanul, selle valmistamismeetod ja farmatseutiline preparaat
NO20010219L (no) Polycykliske tiazolidin-2-ylidenaminer, fremgangsmÕte for deres fremstilling og deres anvendelse som legemiddel
NO992999D0 (no) Farmas°ytisk blanding for oral administrering
DE60003662D1 (de) Pyridothienodiazepine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
EE200000401A (et) Farmatseutilise preparaadi valmistamismeetod
PT1117420E (pt) Composicoes farmaceuticas baseadas em alfa-ciclodextrina para administracao oral de analogos de lh-rh
EE200100609A (et) Tsinnamoüülaminoalküül-asendatud benseensulfoonamiidi derivaat, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning kasutamine ravimina
NO20003284D0 (no) Farmasøytisk preparat for oral administrering
BR9708238A (pt) Formulação farmacêutica para administração oral e processo para preparar a mesma
BR1100047A (pt) Preparação farmacêutica para administração oral, processo para a manufatura da mesma, e, uso da mesma.
SI1222163T1 (sl) 2'-substituirani 1,1'-bifenil-2-karboksamidi, postopek za njihovo pripravo, njihova uporaba kot zdravilo, kot tudi farmacevtski pripravki, ki jih vsebujejo